An EPO Sample, a Sydney Crown and the Empty Interval Between: The Peres Jepchirchir Case

At the 37th kilometre of the Sydney Marathon, when Peres Jepchirchir pushed the pace again, the commentary settled on a single word: experience. Two hours, eighteen minutes, thirty-one seconds. More than three minutes clear of Irene Chepet Cheptai. I watched that race from Los Angeles on a Saturday afternoon, because Sydney's Sunday morning arrives here as the previous day's sunlight. At the finish she glanced at her wrist, then at the stands, and I recognised the look — a runner who already knows that the race she has just left is now part of her biography.

Three weeks later came the notice from the Athletics Integrity Unit. And in that notice was the sentence that moves the story away from where newspapers want to keep it. The sample had been provided in Kenya, out of competition, before she flew to Sydney. Which means the crown handed out on the morning of 30 August 2026 was awarded before the result that will decide whether it stands. The race took two hours and eighteen minutes; the wait took three weeks; the sample predated both. None of that interval appears in any ledger.

I have been writing about that interval for twelve years. Rita Jeptoo's out-of-competition sample was collected in Kenya in September 2026 and the EPO confirmation came at the end of October; in between she won the Chicago Marathon. Jemima Sumgong returned from Rio an Olympic champion and was tested after. Asbel Kiprop, any of them — the architecture is identical. The athlete wins first, the question arrives second, and by the time it arrives the prize money, the ranking points and the series points have gone warm. The ledger does not lie. It simply speaks late.

Context: the résumé that makes this case large

Jepchirchir is 33, and her record is such that in another athlete's name this might not have reached a front page. She won the women's marathon at the Tokyo 2026 Olympics, in Sapporo. In September 2026 she returned to the same country and won the World Championships. The list of women holding both an Olympic and a world marathon title simultaneously is very short, and her name is on it. She set the half-marathon world record in 2026 and broke it three more times in 2026.

A detail belongs here, because it is the difference between a CV and an actual record. Since 2026 the half marathon has carried two categories — the mixed-race record and the women-only record. Jepchirchir's marks were women-only, set in races without male pacers. The media release that says "world record" does not say which. For me the proof of an athlete's capacity is the mark that sits on a certificate, with a date, in a category — not the title printed on a brochure.

Her road record runs in the same straight line: New York 2026, Boston 2026, London 2026. Four majors, an Olympic gold, a world title. And now Sydney, which became the seventh Abbott World Marathon Majors race in 2026. Sydney's admission means Australia is no longer just a race but a scoring entity; the points earned there feed directly into championship selection and series prize money. On the day an athlete wins the seventh major, her name enters not only the race record but the series scoring sheet. And nobody audits a scoring sheet.

Kenya's structure is not background in this case; it is a witness. In 2026 the World Anti-Doping Agency declared Kenya non-compliant, and the status was restored two years later. World Athletics keeps Kenya in the highest-risk category, which means extra testing, extra paperwork, extra cost. The AIU's budget is funded by World Athletics and by member federations — that is, by the same system the athletes run under. This is not a conspiracy; it is the accounting that is true of every anti-doping body and is ignored at every press conference.

Core: EPO, the sample, and the arithmetic that misses the story

EPO — erythropoietin — is a natural substance produced in the kidneys that stimulates the creation of new red blood cells. Injected, it raises red-cell count, and red cells carry oxygen to muscle. In a marathon that translates directly into oxygen delivery across more than two hours of sustained work. There is no serious argument for EPO in a sprint; there is one in a marathon.

The physics of detection matter. Injected EPO is detectable in urine or blood only for a short window, and the method, the timing of collection and the dose together define that window. This is why modern anti-doping is no longer a positive-negative game; the Athlete Biological Passport is the slow, cumulative ledger in which blood parameters shift over months without a single sample testing positive. Here the notice says the sample tested positive — this is a conventional EPO test, not a passport case. That changes the shape of the argument: a passport case is fought over data, a direct positive is fought over the B-sample and the method.

Now the part I always look for — where and when the sample was taken. In Kenya, out of competition, before the race. That is the window in which a marathoner is at her most controlled: taper, travel, sleep, food, supplements. The entire rationale for out-of-competition testing is to cover the period in which an athlete is preparing to look clean. Why EPO in that window, and on whose schedule, is a question for the investigators, not the newspapers. But assuming that every positive equals a systematic doping programme is the laziness I stopped indulging in 2026.

That year I spent nine days at the National Institute of Sports in Patiala asking the boring question nobody was asking: who signed off on these athletes' supplements? In most cases, nobody. Four of the six held sports-quota posts with Railways or a state police force, where the "team doctor" was a visiting physician on a monthly roster, not a staff member. Kenya runs the same architecture under different names — police, prisons, defence forces. The athlete receives a salary, a rank and an identity; in exchange she carries the force's name into races. Exactly as the Railways or PSU job, not prize money, is the real contract an Indian athlete runs on.

So when a woman marathoner is provisionally suspended, the question is not only about a title. It is about whether the salary stops, on which date the medical cover lapses, whose desk her coach's contract is sitting in. That is the ledger I read before the rulings, because an athlete's life is financed by a wage, not a trophy.

Now the Sydney numbers. 2:18:31 is roughly 3:17 per kilometre. Spread three minutes across 42.195 kilometres and you get about 4.3 seconds per kilometre. In elite marathon terms that is a winner a stride ahead at every marker — not theatrical, but entirely decisive. It is the gap that tends to appear when one athlete holds rhythm past 30km and the other breaks.

What gets annulled, and what never gets recovered

A provisional suspension does not erase the Sydney result. It locks that result in a room whose key is held by the B-sample and a hearing. If the charge is proved, the list of what is withdrawn can be itemised: the Sydney title, the prize money, the World Marathon Majors series points, the World Athletics ranking points, and the standing that determines next season's invitations and appearance fees.

And what cannot be withdrawn: the moment at 37km, the noise in the stadium, the commentary already committed to broadcast. A exoneration never receives the space an accusation does; that is not a failure of journalism but a feature of the process. A notice is a public document. A clearance is usually a PDF nobody opens. On the day of the charge an athlete's income stops; on the day of her clearance, no cheque comes back.

There is no uniform timetable. B-sample analysis, explanation, an independent panel, and then the Court of Arbitration for Sport if required. I picked up Dutee Chand's case in 2026, when the AFI suspended her under the hyperandrogenism regulations, and in July 2026 CAS suspended those rules for two years. Everyone filed it as a science story. I built a spreadsheet: her national junior records at 100m and 200m, the prize money and quota-job eligibility lost per month of ineligibility, the cost of the medical panel that examined her. The numbers were embarrassingly small. That was the story. I counted the empty chairs in that courtroom before I counted the rulings — who sat in the hearing, which reporters turned up, how long the room stayed empty.

The same method applies here. A large share of Jepchirchir's earnings comes from majors appearance fees and prizes, which go cold from the day of suspension. Follow the money to the rulebook; it says an athlete under provisional suspension may not compete, for any federation, in any major. At 33, a four-year ban is retirement and a two-year ban is a second career. If she is cleared, the damage is uninsurable.

Contrarian: "Kenya again" is a lazy frame

This story will be written three ways. One: the crisis in Kenyan athletics, the same film again. Two: the fall of an Olympic champion, a human tragedy. Three: a warning piece about EPO. All three share one omission — none of them contains the interval in which the real decisions had already been taken.

What irritates me most is that the system collected a sample, let the athlete race, let her win, let her be crowned, and then issued a notice. No individual step was technically wrong. Results take time; everyone knows that. But the titles distributed before a result arrives are not marked conditional. The majors could decide that an athlete with an outstanding out-of-competition sample has her result recorded as pending and her prize held. No such rule exists, because such a rule would slow the series' marketing.

The second contrarian point is that an EPO positive is not by itself proof of a systematic programme. Micro-dosing, a contaminated supplement, a medical product, something handed over in that window and described as "just iron and vitamins" — all of it runs through the B-sample and the hearing. I am not saying that is what happened. I am saying that deciding the story is over on the day the notice lands is the same impatience that had my 2026 model giving Krishna Poonia a 4% chance of discus gold. On 11 October 2026 she threw 63.69m, and my model finished 11th of 14 in its own accuracy table. The model was wrong, not the athlete.

The third angle is the least comfortable. When a woman's case breaks, the argument moves to her body — blood, hormones, muscle, age, motherhood, comeback. When a man's case breaks, the argument moves to procedure — chain of custody, collection, laboratory, right to a hearing. I have watched that asymmetry in every case. The risk here is that the headlines stop at 2:18:31 and the number 33, and nobody asks who collected the sample, which laboratory received it, where the custody form is, and who read the supplement list. The day a woman athlete's case is printed as the story of her body, procedure goes free — and procedure going free always benefits the side with lawyers.

One fact here is already fixed and cannot be spun: the sample predates the race. Sydney is therefore not a performance that followed the sample; it is one that preceded it. If the charge is proved, it becomes reasonable to question that performance too, because the days before a race are exactly when EPO's effect persists. If she is cleared, that same fact becomes the strongest part of her defence — one old sample, no new suspicion between collection and result. This is why I read the story not as a doping case but as a timeline case.

There is another layer that is easy to ignore in the Kenyan context. A generation of Kenyan women marathoners came up with fewer races, less sponsorship and less legal support than the men. Jepchirchir built that résumé anyway — four majors, an Olympic title, a world title. The achievement is on the record and predates any suspension; a suspension does not stamp it out. Most of the people writing "fraud" today could not produce a line about her last six kilometres in London 2026. Sporting memory is very short, and that short memory is precisely what keeps the anti-doping system from ever being held to account.

Forward: three questions that belong in the ledger

The next step is the B-sample. If it too is positive, a hearing begins and a decision lands in months, during which the Sydney title, the series points and the ranking all sit in a pending category — provided anyone has decided to declare them pending. If the B-sample is negative or the process is found flawed, the question becomes who accounts for the damage done in that interval: sponsors, appearance fees, training camps. No anti-doping code has a column for it.

Three things I will be watching. First, whether the collection date is published; without a date a case becomes ahistorical and each side builds the version that suits it. Second, when the majors decide what a pending result does to series standings — because in a seven-race structure one athlete's points determine other athletes' prize money, and those other athletes are not being called as witnesses. Third, whether the chain-of-custody paperwork and the supplement declaration from that collection are released on the same day as the charge, because what I saw most in Patiala in 2026 was not doping. It was the emptiness of the paperwork.

Jepchirchir is 33. If this goes against her, Sydney may be her last big win, and that win may be struck from the record book. If it does not, she remains the winner of a race whose crown passed through a room with no spectators in it. Either way one thing is constant: the verdict did not arrive on the day the truth was known. My question is simpler than the case. If an athlete cannot wait 42.195 kilometres, why does the system need three weeks to write down what it already knows — and which title, which cheque and which record moves forward unsigned in the meantime?